Evaluation and Modeling with the Therapeutic Effects Group
Members
Maîtresse de conférences - praticienne hospitalière
UCBL
Tel: 04 72 11 94 07
Maître de conférences - praticien hospitalier
UCBL
Tel: 33 04 72 32 34 87
Professeur des universités - médecin généraliste
UCBL
Tel: 04 78 74 18 18
Maîtresse de conférences
UCBL
Tel: 33 04 78 78 57 83
Professeure des universités - médecin généraliste
UCBL
Tel: 04 78 77 72 86
Professeur d'université - praticien hospitalier
UCBL
Tel: 04 72 44 81 42
Doctorante
HCL
Assistant hospitalier universitaire
UCBL
Doctorant
UCBL
Tel: 04 72 44 81 42
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 16 80 99
Doctorante
autre
Tel: 04 72 44 81 42
Praticien hospitalier
HCL
Tel: 04 72 44 81 42
Professeur d'université - praticien hospitalier émérite
UCBL
Professeur d'université - praticien hospitalier
UCBL
Tel: 04 27 85 77 32
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 78 86 33 01
Post-doc
UCBL
Maîtresse de conférences - praticienne hospitalière
UCBL
Maître de conférences - praticien hospitalier
UCBL
Tel: 04 72 11 94 20
Doctorante
UCBL
Professeur d'université - praticien hospitalier
UCBL
Tel: 33 04 72 12 94 37
Post-doc
UCBL
Doctorante
UCBL
Tel: 04 72 44 81 42
EMET presentation
The EMET team brings together doctors, pharmacists and research professors specializing in the evaluation and use of drug and non-drug therapies, around a single project built on two axes:
- the evaluation of therapies in clinical trials or observational studies;
- the construction of explanatory and predictive models, to better understand and therefore predict the effect of therapies, simulate their impacts at the individual and population level, and improve the innovation paradigm.
The EMET team is therefore part of two major dynamics in therapy: analysis of the level of evidence and precision medicine.
The fields of application are cardiovascular and metabolic diseases, primary care medicine, rare pediatric diseases (including genetic and autoimmune diseases), oncology and infectious diseases.
EMET members implement approaches using different mathematical models: direct comparison and network meta-analysis, pharmacokinetic/pharmacodynamic analysis, Bayesian networks and machine learning.
Education
The EMET team is specially involved in the teaching of pharmacology and therapeutics and the modeling of the treatment effect through the coordination of the Masters 2 Clinical Evaluation (EC) and Pharmacology modeling and clinical trials (PHAME), Interpretation of Therapeutic Trials (IET), Training of investigators in clinical drug trials (FIEC) and Training of clinical research assistants and clinical study technicians (FARCTEC). Teacher-researchers are also involved in the first (pharmacology), second (pharmacology / therapeutics, pharmacy) and third cycles (general medicine, pediatrics, internal medicine) in health training courses.
Society involvement
The members of the EMET team through their work and their interactions with the other components of the LBBE, National societies, governmental (HAS) or international (EMA) agencies, and the Hospices Civils de Lyon, are invested in current societal issues: rationalization of the use of health product resources, research ethics, gender equality, rationality of approaches in analyzing the diversity of human populations.
Publications
Display of 121 to 150 publications on 613 in total
Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis
Pharmaceutics . 14 ( 8 ) : 1750
Journal article
see the publicationSeventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm
Open Forum Infectious Diseases . 9 ( 11 ) : ofac577
DOI: 10.1093/ofid/ofac577
Journal article
see the publicationPredicted Impacts of Booster, Immunity Decline, Vaccination Strategies, and Non-Pharmaceutical Interventions on COVID-19 Outcomes in France
Vaccines . 10 ( 12 ) : 2033
Journal article
see the publicationAn Investigation of O-Demethyl Tramadol/Tramadol Ratio for Cytochrome P450 2D6 Phenotyping: The CYTRAM Study
Pharmaceutics . 14 ( 10 ) : 2177
Journal article
see the publicationSelected and simplified FDI criteria for assessment of restorations
Journal of Dentistry . 122 : 104109
Journal article
see the publicationHow do they add up? The interaction between the placebo and treatment effect: A systematic review
British Journal of Clinical Pharmacology . 88 ( 8 ) : 3638-3656
DOI: 10.1111/bcp.15345
Journal article
see the publicationPlace of a new radiological index in predicting pulp exposure before intervention for deep carious lesions
Oral Radiology . 38 ( 1 ) : 89-98
Journal article
see the publicationCharacteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract
Seminars in Arthritis and Rheumatism . 51 ( 2 ) : 436-441
Journal article
see the publicationParaneoplastic polyarteritis nodosa in a patient with cutaneous T-cell lymphoma
The Lancet Haematology . 8 ( 3 ) : e240
Journal article
see the publicationOlaparib in recurrent IDH-mutant high-grade glioma (OLAGLI)
57th Annual Meeting of the American Society of Clinical Oncology (2021 ASCO Annual Meeting) . 39 ( 15S ) : 2007
Conference paper
see the publicationArterial and venous thromboembolism in COVID-19: a study-level meta-analysis
Thorax . 76 ( 10 ) : 970-979
Journal article
see the publicationTwice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis
Thrombosis Research . 197 : 24 - 32
Journal article
see the publicationTwice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis
Thrombosis Research . 197 : 24-32
Journal article
see the publicationInflammation of Unknown Origin: Evaluation and Prognosis of 57 Cases
Journal of Clinical Medicine . 11 ( 1 ) : 32
DOI: 10.3390/jcm11010032
Journal article
see the publicationRisk Factors for Venous Thromboembolism in Severe COVID-19: A Study-Level Meta-Analysis of 21 Studies
International Journal of Environmental Research and Public Health . 18 ( 24 ) : 12944
Journal article
see the publicationVenous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: A systematic review with meta-analysis
Vascular Pharmacology . 139 : 106882
Journal article
see the publicationAssessing the management of major bleeding events in patients treated by direct oral anticoagulant in an emergency department
Annales de Biologie Clinique . 79 ( 4 ) : 315-324
Journal article
see the publicationMeta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality
Scientific Reports . 11 ( 1 ) : 14728
Journal article
see the publicationMeta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality
Scientific Reports . 11 ( 1 ) : 14728
Journal article
see the publicationSignificant Major Bleeding in Hospitalized Patients with COVID-19 Receiving Thromboprophylaxis
Thrombosis and Haemostasis . 121 ( 12 ) : 1670-1673
DOI: 10.1055/a-1477-4027
Journal article
see the publicationCharacteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract
Seminars in Arthritis and Rheumatism . 51 ( 2 ) : 436-441
Journal article
see the publicationCharacteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract
Seminars in Arthritis and Rheumatism . 51 ( 2 ) : 436-441
Journal article
see the publicationParaneoplastic polyarteritis nodosa in a patient with cutaneous T-cell lymphoma
The Lancet Haematology . 8 ( 3 ) : e240
Journal article
see the publicationDirect oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: A systematic review with meta-analysis
Pharmacological Research . 163 : 105317
Journal article
see the publicationDPP-4 Inhibitors and Respiratory Infection: A Systematic Review and Meta-analysis of the Cardiovascular Outcomes Trials
Diabetes Care . 44 ( 3 ) : e36-e37
DOI: 10.2337/dc20-2018
Journal article
see the publicationPrevention of venous thromboembolism in nephrotic syndrome: the quest towards precision medicine
Nephrology Dialysis Transplantation . 36 ( 7 ) : 1151-1154
DOI: 10.1093/ndt/gfaa337
Journal article
see the publicationBladder endometriosis: Preoperative MRI analysis with assessment of extension to ureteral orifices
Diagnostic and Interventional Imaging . 102 ( 4 ) : 255-263
Journal article
see the publicationSplenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment
American Journal of Hematology . 97 ( 1 ) : 10-17
DOI: 10.1002/ajh.26378
Journal article
see the publicationArterial and venous thromboembolism in COVID-19: a study-level meta-analysis
Thorax . 76 ( 10 ) : 970-979
Journal article
see the publicationPopulation Pharmacokinetic Modeling and Dosing Simulations of Tobramycin in Pediatric Patients with Cystic Fibrosis
Antimicrobial Agents and Chemotherapy . 65 ( 10 ) : e0073721
DOI: 10.1128/AAC.00737-21
Journal article
see the publication
You also, comment on this article